Growth Metrics

Conmed (CNMD) Free Cash Flow Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -1.82%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 226.77%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 9.73%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -51.69%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -109.40%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 133.09%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 363.84%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 108.16%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 29.12%
10 Conmed 1.06 Bn 1.02 Bn 183.45 Mn -71.98%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -71.98%
Dec 31, 2025 4.90%
Sep 30, 2025 1.50%
Jun 30, 2025 -41.07%
Mar 31, 2025 39.39%
Dec 31, 2024 -23.75%
Sep 30, 2024 17.31%
Jun 30, 2024 79.35%
Mar 31, 2024 434.35%
Dec 31, 2023 398.37%
Sep 30, 2023 112.35%
Jun 30, 2023 69.93%
Mar 31, 2023 -141.17%
Dec 31, 2022 -156.46%
Sep 30, 2022 21.51%
Jun 30, 2022 -58.35%
Mar 31, 2022 -117.46%
Dec 31, 2021 80.02%
Sep 30, 2021 -50.42%
Jun 30, 2021 1,650.70%
Mar 31, 2021 2,046.76%
Dec 31, 2020 -51.00%
Sep 30, 2020 0.34%
Jun 30, 2020 -89.23%
Mar 31, 2020 111.28%
Dec 31, 2019 73.89%
Sep 30, 2019 29,211.01%
Jun 30, 2019 -3.06%
Mar 31, 2019 -137.39%
Dec 31, 2018 15.96%
Sep 30, 2018 -101.12%
Jun 30, 2018 30.79%
Mar 31, 2018 67.05%
Dec 31, 2017 83.47%
Sep 30, 2017 -55.80%
Jun 30, 2017 -0.14%
Mar 31, 2017 165.72%
Dec 31, 2016 8.19%
Sep 30, 2016 120.59%
Jun 30, 2016 100.89%
Mar 31, 2016 -280.01%
Dec 31, 2015 -61.46%
Sep 30, 2015 -9.42%
Jun 30, 2015 96.98%
Mar 31, 2015 -17.07%
Dec 31, 2014 0.30%
Sep 30, 2014 -56.20%
Jun 30, 2014 -75.67%
Mar 31, 2014 865.72%
Dec 31, 2013 -20.99%
Sep 30, 2013 6.44%
Jun 30, 2013 -33.53%
Mar 31, 2013 11.37%
Dec 31, 2012 32.56%
Sep 30, 2012 -27.10%
Jun 30, 2012 35.69%
Mar 31, 2012 -92.72%
Dec 31, 2011 12.20%
Sep 30, 2011 492.56%